Why a COSHH-aware inventory is more than a stock list
A reagent inventory becomes COSHH-aware when it records not only what is on the shelf but also how the material must be controlled, who may use it, where it is stored and how it will be removed from service. For a UK-sourced research vial, that distinction matters at receipt. A delivery note may confirm arrival, but the inventory entry should connect the physical vial to its documentation, storage conditions and local risk assessment. The aim is a traceable laboratory record that can survive a quarterly review, a colleague’s absence or a safety inspection without relying on memory.
The record as a control document
Start with the principle that the inventory is a control document, not a shopping list. Each line should answer four practical questions: what is the material, what documentation accompanies it, where is it kept and what is the disposal route? For research-use-only materials, the supplier’s published position is part of the record. Research Sciences describes its catalogue as strictly for controlled laboratory and analytical research, with products labelled “For Research Use Only – Not for Human Consumption”. The local inventory should echo that message: items are not for human or veterinary use and must not be repurposed as medicines, supplements or clinical materials.
Good entries also prevent silent drift. A vial may move from a −20°C freezer to a 2–8°C refrigerator after reconstitution in an in-vitro workflow; stock may be split into working aliquots; an expiry date may approach during the quarter. If these changes are absent from the inventory, the quarterly reagents review loses evidential value. The record should be proportionate to risk but complete enough for a materials manager to see the item’s status at a glance. That means unique identifiers, supplier details, label references, storage class, receipt date and the current CoA location. It also means a clear note when a vial is quarantined, awaiting documentation or due for disposal.
Step-by-step entry of a UK-sourced vial before the quarterly review
Receipt is the best moment to create a clean record. Work at a designated receiving bench, keep the parcel and vial labels visible, and enter the item into the inventory before it is placed in long-term storage. If the package has been in transit, allow the vial to equilibrate to ambient temperature before opening in the research setting, in line with local handling procedures. Record the date of receipt, supplier, product name, catalogue or SKU code, quantity, physical form and any label reference. Where the vial label follows the supplier’s SKU-plus-expiry format, such as BPC10-03/27, transcribe it exactly and attach the corresponding CoA to the inventory record. Do not guess missing characters or substitute a similar catalogue item.
Documentation, storage and release
Next, link the physical item to its batch documentation. For a UK-sourced lyophilised research vial, the batch CoA is the primary analytical reference; the supplier’s live page and batch document should be checked because headline purity figures and reports can change between batches. Research Sciences lists independent testing, transparent CoAs and temperature-aware storage among its published positions, and the homepage refers to “CoAs Janoshik Analytical Reports”; the researcher should open and check the CoA that accompanies the specific batch rather than relying on a general webpage claim. If an Internal Test Reference appears on the paperwork, record it as a link to associated reports, but do not treat it as proof that separate deliveries share a production lot. Cap colour and packaging should not be used as identity or quality indicators.
The storage entry should be equally specific. Record the storage location, temperature class, desiccant status, light protection and any freeze–thaw restrictions. Lyophilised materials are typically stored at −20°C or below, sealed with desiccant and protected from moisture, heat and light; reconstituted material is less stable and should be held at 2–8°C for short-term laboratory use where the local protocol allows. For a vial sourced through Peptide uk, the inventory should also capture the RUO label statement and the local COSHH assessment reference. If the experimental workflow involves reconstitution, record the diluent volume and target in-vitro concentration in the assay record only; the supplier’s calculator is for laboratory research use and must not be used for human or veterinary dosing. Finally, add a quarantine flag for any missing CoA, unclear label or damaged vial, and do not release it to the bench until the materials manager has resolved the query.
Making the quarterly reagents review defensible and useful
Once entries are in place, the quarterly review should test the inventory rather than merely print it. Set a review window, walk the storage locations and compare the physical vial against the record: label reference, quantity, seal integrity, storage temperature, expiry date and CoA availability. Mark items that are due to expire, have been opened for an in-vitro workflow, have lost desiccant protection or are awaiting disposal. This is also the point to reconcile any Internal Test Reference notes with the supplier’s documentation, asking for clarification where a delivery’s testing status is not clear. A short, consistent checklist is more useful than a lengthy narrative because it gives the reviewer a repeatable standard across reagents and suppliers.
Closing gaps before they become findings
The review should close gaps before they become findings. If a CoA is missing, move the vial to quarantine and record the action. If a storage category has changed, update the COSHH assessment and the inventory together rather than treating them as separate systems. If a vial is no longer required, record the disposal route approved by the laboratory and remove it from active stock. Researchers should remember that the purchaser remains responsible for lawful use, safe handling, storage and disposal, and for compliance with UK regulations including COSHH. The supplier’s RUO labelling is a starting point, not a substitute for a local risk assessment. Repeat the message in team briefings: materials are not for human or veterinary use, and reconstitution must stay within an in-vitro laboratory workflow.
A well-run review also improves future ordering. Patterns of expiry, repeated documentation queries or storage congestion can inform purchasing decisions without inventing demand. Keep the audit trail concise: review month, reviewer, sample locations checked, discrepancies, corrective actions and closure date. Where the supplier’s current published wording is cited — purity, order counts, delivery estimates or CoA references — note that it is a published figure and should be reconfirmed on the live page and batch CoA. Record each action against the vial’s inventory line so the next quarterly reagents review begins with evidence rather than assumption.
